Welcome to TRIZ Biopharma Innovation, the pioneering company behind Dynamic Self-Adapting Medical Drugs. We have developed a groundbreaking discovery that introduces a new paradigm in precision medicine—personalized and adaptive treatments that evolve in response to each patient’s unique biology. Unlike conventional drugs constrained by genetic variances, our dynamic drugs act like a ‘bunch of skeleton keys,’ ensuring nearly 100% efficacy by adapting to diverse biological targets. This revolutionary methodology integrates over 40 years of innovation, leveraging TRIZ (Theory of Inventive Problem Solving, based on patterns of evolution) in medicine and pharmaceuticals, along with cutting-edge AI technologies, to open the door to a transformative era in medicine. Join us as we redefine the future of healthcare with our visionary approach Our Vision: Making drugs smart Our Mission: Making the dream of personalized medicine come true: delivering smart drugs customized for everybody.
Boris Farber
Ph.D, Dr. Sci. Academician Chief Executive Officer
ILya Kleyn
M.D., Medical Advisor
Daniel L. Beckles
M.D.,Ph.D.,FACS,FACC,FCCP Chief Research Officer
Eduardo Javier Mascareno
Ph.D., Chief Research Officer
Irina E. Catrina
Ph.D., Assistant Professor of Chemistry Advisor in Chemistry
Suzanna Katz
Ph.D., Senior Scientist
Stella Ilyayeva
MD, Advisor, Endocrinology
Alexander A. Katz
Prof., Ph.D., D.Sci. Advisor Math Modeling and Drug Design
Avi Kamelhar
MPA, Business Advisor
Predrag-Peter Ilich
Dr., Regulatory Affairs and Compliance
James A. Warshaw
Ph.D, MD, ECNU, Advisor, Organic chemistry
Gabriel Ilyayev
Ph.D., Advisor, Pharmacology